<DOC>
	<DOCNO>NCT00334152</DOCNO>
	<brief_summary>This study conduct see add GW679769 ( casopitant ) ZOFRAN significantly decrease number patient experience nausea vomit surgery .</brief_summary>
	<brief_title>Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Neurokinin-1 Receptor Antagonists</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Inclusion criterion : History PONV ( postoperative nausea vomit ) and/or motion sickness . Have smoke last 6 month . Having certain abdominal , breast , thyroid shoulder surgery . Exclusion criterion : Pregnant breastfeeding . Have certain preexist medical condition take certain medication .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>NK-1</keyword>
	<keyword>antiemetic</keyword>
	<keyword>casopitant mesylate</keyword>
	<keyword>postoperative nausea vomit</keyword>
	<keyword>ondansetron hydrochloride</keyword>
	<keyword>5HT3</keyword>
	<keyword>ZOFRAN</keyword>
	<keyword>PONV</keyword>
</DOC>